PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15378516-9 2004 Furthermore, lovastatin is able to suppress microglial tumor necrosis factor-alpha, interleukin (IL)-beta1 and IL-6 production promoted either by IFN-gamma or by Abeta peptide challenge in the presence of CD40 cross-linking. Lovastatin 13-23 interleukin 6 Homo sapiens 111-115 31013450-4 2019 Lovastatin treatment resulted in increased levels of IL-6, IL-12p40, and IFN-gamma mRNA in both PBMCs and monocytes following LPS stimulation compared with control cells. Lovastatin 0-10 interleukin 6 Homo sapiens 53-57 34607230-8 2021 Besides, in patients, receiving lovastatin the CRP, IL-6, IL-8 levels were significantly decreased from T1 to T3 than to the control group. Lovastatin 32-42 interleukin 6 Homo sapiens 52-56 10631097-0 2000 Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin. Lovastatin 147-157 interleukin 6 Homo sapiens 46-59 10631097-7 2000 Lovastatin markedly inhibited mesangial cell expression of IL-6 mRNA and reduced IL-6 secretion. Lovastatin 0-10 interleukin 6 Homo sapiens 59-63 10631097-7 2000 Lovastatin markedly inhibited mesangial cell expression of IL-6 mRNA and reduced IL-6 secretion. Lovastatin 0-10 interleukin 6 Homo sapiens 81-85 25374755-12 2014 Activated BEAS-2B cells treated with lovastatin exhibited reduced IL-6, eotaxins (CCL11 and CCL24), and intercellular adhesion molecule-1 protein expression. Lovastatin 37-47 interleukin 6 Homo sapiens 66-70 16968805-13 2006 Lovastatin significantly decreased Rho kinase and nuclear factor-kappaB activity, significantly increased Akt activity, and resulted in decreased monocyte IL-6 levels; these effects were reversed with mevalonate and geranylgeranyl pyrophosphate, indicating direct effects of statins on protein prenylation. Lovastatin 0-10 interleukin 6 Homo sapiens 155-159 20214221-7 2009 Lovastatin administration resulted in the significant decrease of the pro-inflammatory cytokines IL-6 and TNF-alfa, while that of fluvastatin brought about the significant decrease of the serum levels of IL-6, IL-8 and TNF-alfa. Lovastatin 0-10 interleukin 6 Homo sapiens 97-101 20214221-10 2009 CONCLUSIONS: Lovastatin and fluvastatin, significantly decrease the level of viremia, of IL-6 and TNF-alpha in the patients with chronic hepatitis C. Lovastatin 13-23 interleukin 6 Homo sapiens 89-93